Literature DB >> 17024113

t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene.

C T Storlazzi, F Albano, C Locunsolo, A Lonoce, S Funes, M C Guastadisegni, L Cimarosto, L Impera, P D'Addabbo, I Panagopoulos, G Specchia, M Rocchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17024113     DOI: 10.1038/sj.leu.2404418

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  12 in total

1.  Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities.

Authors:  Christopher B Benton; Maria Tanaka; Catherine Wilson; Sherry Pierce; Lingsha Zhou; Jorge Cortes; Hagop Kantarjian; Srdan Verstovsek
Journal:  Leuk Res       Date:  2015-02-02       Impact factor: 3.156

2.  Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma.

Authors:  Simona Ruggieri; Roberto Tamma; Nicoletta Resta; Francesco Albano; Nicoletta Coccaro; Daria Loconte; Tiziana Annese; Mariella Errede; Giorgina Specchia; Rebecca Senetta; Paola Cassoni; Domenico Ribatti; Beatrice Nico
Journal:  Oncotarget       Date:  2017-05-09

3.  HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma.

Authors:  Alexandra C Hristov; Leslie Cope; Marcelo Delos Reyes; Mansher Singh; Christine Iacobuzio-Donahue; Anirban Maitra; L M S Resar
Journal:  Mod Pathol       Date:  2008-08-29       Impact factor: 7.842

4.  Hmga2 is a direct target gene of RUNX1 and regulates expansion of myeloid progenitors in mice.

Authors:  Kentson Lam; Alexander Muselman; Randal Du; Yuka Harada; Amanda G Scholl; Ming Yan; Shinobu Matsuura; Stephanie Weng; Hironori Harada; Dong-Er Zhang
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

5.  TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing.

Authors:  Crescenzio Francesco Minervini; Cosimo Cumbo; Paola Orsini; Claudia Brunetti; Luisa Anelli; Antonella Zagaria; Angela Minervini; Paola Casieri; Nicoletta Coccaro; Giuseppina Tota; Luciana Impera; Annamaria Giordano; Giorgina Specchia; Francesco Albano
Journal:  Diagn Pathol       Date:  2016-10-10       Impact factor: 2.644

6.  Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia.

Authors:  Angela Minervini; Crescenzio Francesco Minervini; Luisa Anelli; Antonella Zagaria; Paola Casieri; Nicoletta Coccaro; Cosimo Cumbo; Giuseppina Tota; Luciana Impera; Paola Orsini; Claudia Brunetti; Annamaria Giordano; Giorgina Specchia; Francesco Albano
Journal:  Oncotarget       Date:  2016-12-27

7.  Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms.

Authors:  Chih-Cheng Chen; Jie-Yu You; Jrhau Lung; Cih-En Huang; Yi-Yang Chen; Yu-Wei Leu; Hsing-Ying Ho; Chian-Pei Li; Chang-Hsien Lu; Kuan-Der Lee; Chia-Chen Hsu; Jyh-Pyng Gau
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

Review 8.  Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.

Authors:  Nicoletta Coccaro; Giuseppina Tota; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

9.  Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells.

Authors:  Kazutaka Ouchi; Mitsuru Miyachi; Shigeki Yagyu; Ken Kikuchi; Yasumichi Kuwahara; Kunihiko Tsuchiya; Tomoko Iehara; Hajime Hosoi
Journal:  Cancer Cell Int       Date:  2020-05-24       Impact factor: 5.722

Review 10.  TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings.

Authors:  Cosimo Cumbo; Giuseppina Tota; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.